Close



Oct 23, 2023 07:01AM
Oct 23, 2023 07:00AM
Sep 11, 2023 07:02AM
Sep 11, 2023 07:00AM
Jan 9, 2023 08:31AM
Jan 9, 2023 08:31AM
Jan 9, 2023 08:30AM eGenesis and Eledon Pharmaceuticals Announce Collaboration for Use of Tegoprubart in Preclinical Xenotransplantation Studies
Jan 9, 2023 08:30AM
Nov 14, 2022 04:01PM
Nov 14, 2022 04:01PM
Sep 7, 2022 09:19AM
Sep 6, 2022 05:34PM
Sep 6, 2022 04:03PM
Sep 6, 2022 04:01PM Eledon Pharmaceuticals Receives FDA Clearance of IND Application to Evaluate Tegoprubart in IgA Nephropathy
Sep 6, 2022 04:01PM
Aug 11, 2022 04:01PM
Aug 11, 2022 04:01PM
Aug 1, 2022 05:49AM
Aug 1, 2022 05:00AM
Aug 1, 2022 05:00AM
Jun 9, 2022 08:03AM Eledon Pharmaceuticals (ELDN) Announces Orphan Drug Designation Granted to Tegoprubart for the Prevention of Allograft Rejection in Pancreatic Islet Cell Transplantation
Jun 9, 2022 08:00AM
Jun 9, 2022 08:00AM
May 31, 2022 06:09AM
May 31, 2022 06:00AM
May 31, 2022 06:00AM
Mar 24, 2022 04:01PM
Mar 24, 2022 04:01PM Eledon Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Operating and Financial Results
Feb 14, 2022 08:03AM
Feb 14, 2022 08:00AM
Nov 11, 2021 04:05PM
Aug 12, 2021 04:01PM
May 13, 2021 04:01PM
Apr 26, 2021 04:26PM
Apr 26, 2021 04:05PM Eledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation
Mar 23, 2021 09:28AM
Mar 22, 2021 05:44PM

251,890 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All